<sub id="np7fh"><dfn id="np7fh"></dfn></sub>
        <sub id="np7fh"><var id="np7fh"><ins id="np7fh"></ins></var></sub>

        <sub id="np7fh"><dfn id="np7fh"></dfn></sub><address id="np7fh"></address>

        <thead id="np7fh"><var id="np7fh"><ins id="np7fh"></ins></var></thead>
        <thead id="np7fh"><var id="np7fh"><ruby id="np7fh"></ruby></var></thead>
        <address id="np7fh"></address><sub id="np7fh"><dfn id="np7fh"></dfn></sub>

        <sub id="np7fh"><dfn id="np7fh"><output id="np7fh"></output></dfn></sub><sub id="np7fh"><var id="np7fh"></var></sub>

          <address id="np7fh"><listing id="np7fh"><ins id="np7fh"></ins></listing></address>

            <sub id="np7fh"><var id="np7fh"><ins id="np7fh"></ins></var></sub>

            Third quarter 2019 results

            Since joining Sanofi only two months ago, I am increasingly excited about the strength of our businesses, our ability to develop transformative medicines and the diverse talent of our teams across the organization.
            Paul Hudson
            Chief Executive Officer
            company sales ans Business EPS

            Infographic third quarter 2019 results

            This website uses cookies to track its audience and improve its content. By continuing to browse this website, you agree to the use of such cookies.

            Click here for more information on cookies
            OK
            4438xx